API australian pharmaceutical industries limited

News: API Australian Pharmaceutical Industries declines Wesfarmers' $501 mln offer

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    July 29 (Reuters) - Australian Pharmaceutical Industries (API) on Thursday declined a A$680 million ($501.43 million) indicative bid from retail conglomerate Wesfarmers (WES) , saying it was opportunistic and undervalued the pharmacy chain.

    "The board will only progress a change of control transaction on terms that recognise the fundamental value of API and are in the best interests of API shareholders as a whole," Australian Pharmaceutical Industries said in an exchange filing.

    ($1 = 1.3561 Australian dollars)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.